Logo image of CVRX

CVRX INC (CVRX) Stock Price, Quote, News and Overview

NASDAQ:CVRX - Nasdaq - US1266381052 - Common Stock - Currency: USD

6.99  +0.14 (+2.04%)

After market: 7.2399 +0.25 (+3.58%)

CVRX Quote, Performance and Key Statistics

CVRX INC

NASDAQ:CVRX (5/20/2025, 8:00:01 PM)

After market: 7.2399 +0.25 (+3.58%)

6.99

+0.14 (+2.04%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High18.55
52 Week Low4.3
Market Cap182.16M
Shares26.06M
Float23.55M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)07-28 2025-07-28/amc
IPO06-30 2021-06-30


CVRX short term performance overview.The bars show the price performance of CVRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

CVRX long term performance overview.The bars show the price performance of CVRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20 -30 -40

The current stock price of CVRX is 6.99 USD. In the past month the price increased by 15.92%. In the past year, price decreased by -6.17%.

CVRX INC / CVRX Daily stock chart

CVRX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.28 234.48B
ISRG INTUITIVE SURGICAL INC 72.93 199.70B
BSX BOSTON SCIENTIFIC CORP 39.46 157.58B
SYK STRYKER CORP 31.09 148.69B
MDT MEDTRONIC PLC 16.17 110.77B
BDX BECTON DICKINSON AND CO 12.54 50.73B
EW EDWARDS LIFESCIENCES CORP 29.93 45.76B
IDXX IDEXX LABORATORIES INC 45.36 41.91B
RMD RESMED INC 27.33 36.38B
DXCM DEXCOM INC 52.93 34.25B
GEHC GE HEALTHCARE TECHNOLOGY 15.62 32.90B
STE STERIS PLC 26.82 24.61B

About CVRX

Company Profile

CVRX logo image CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.

Company Info

CVRX INC

9201 West Broadway Avenue, Suite 650

Minneapolis MINNESOTA US

CEO: Nadim Yared

Employees: 200

CVRX Company Website

CVRX Investor Relations

Phone: 17634162850

CVRX INC / CVRX FAQ

What is the stock price of CVRX INC today?

The current stock price of CVRX is 6.99 USD. The price increased by 2.04% in the last trading session.


What is the ticker symbol for CVRX INC stock?

The exchange symbol of CVRX INC is CVRX and it is listed on the Nasdaq exchange.


On which exchange is CVRX stock listed?

CVRX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CVRX INC stock?

13 analysts have analysed CVRX and the average price target is 17.54 USD. This implies a price increase of 150.99% is expected in the next year compared to the current price of 6.99. Check the CVRX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CVRX INC worth?

CVRX INC (CVRX) has a market capitalization of 182.16M USD. This makes CVRX a Micro Cap stock.


How many employees does CVRX INC have?

CVRX INC (CVRX) currently has 200 employees.


What are the support and resistance levels for CVRX INC (CVRX) stock?

CVRX INC (CVRX) has a resistance level at 7.96. Check the full technical report for a detailed analysis of CVRX support and resistance levels.


Is CVRX INC (CVRX) expected to grow?

The Revenue of CVRX INC (CVRX) is expected to grow by 12.54% in the next year. Check the estimates tab for more information on the CVRX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CVRX INC (CVRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CVRX INC (CVRX) stock pay dividends?

CVRX does not pay a dividend.


When does CVRX INC (CVRX) report earnings?

CVRX INC (CVRX) will report earnings on 2025-07-28, after the market close.


What is the Price/Earnings (PE) ratio of CVRX INC (CVRX)?

CVRX INC (CVRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.18).


What is the Short Interest ratio of CVRX INC (CVRX) stock?

The outstanding short interest for CVRX INC (CVRX) is 5.27% of its float. Check the ownership tab for more information on the CVRX short interest.


CVRX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CVRX. When comparing the yearly performance of all stocks, CVRX is a bad performer in the overall market: 86.28% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CVRX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CVRX. CVRX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CVRX Financial Highlights

Over the last trailing twelve months CVRX reported a non-GAAP Earnings per Share(EPS) of -2.18. The EPS increased by 11.74% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -39.78%
ROE -74.32%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%49.04%
Sales Q2Q%14.65%
EPS 1Y (TTM)11.74%
Revenue 1Y (TTM)25.63%

CVRX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to CVRX. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 24.27% and a revenue growth 12.54% for CVRX


Ownership
Inst Owners67.49%
Ins Owners4.21%
Short Float %5.27%
Short Ratio2.99
Analysts
Analysts81.54
Price Target17.54 (150.93%)
EPS Next Y24.27%
Revenue Next Year12.54%